Broadcom Insider Selling Meets Buy-the-Dip Calls
Broadcom insider selling in June Form 144 filings contrasts with buy-the-dip calls and $500-$580 targets, raising near-term supply risk for traders.
KEY TAKEAWAYS
- Form 144 filings documented proposed June 24 sales and affiliate transfers, raising near-term supply signals.
- Sell-side firms reiterated Buy ratings with $500-$580 price targets, anchoring buy-the-dip narratives.
- Contrast creates a trader debate between near-term supply risk and multi-year AI upside into 2028.
HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX
Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.
Broadcom Inc. saw elevated insider selling documented in Form 144 filings on June 24, 2026, even as sell‑side firms reiterated Buy ratings and raised 12‑month price targets, citing the company’s AI‑chip roadmap and multi‑year AI revenue trajectory.
Insider Filings Detail Share Sales
A Form 144 filed by Northern Trust Securities disclosed a proposed sale of 15,784 shares of Broadcom common stock and noted a prior sale of 9,426 shares on March 25, 2026 [source:7]. An amendment to a Form 144/A recorded transfers and sales by Broadcom affiliates, naming H&S Investments I, LP; the Samueli Foundation; The Rinks Foundation; and D95GT LLC, describing gifted shares alongside resale quantities tied to affiliate holdings [source:4].
A separate Form 144 tied to equity compensation listed 712,354 shares associated with a Restricted Stock Lapse, with related entries dated April 8 and a proposed entry dated April 20, 2026 [source:1]. These filings are procedural notices of proposed sales and transfers under Rule 144 of the Securities Act, not regulatory approvals or enforcement actions.
A secondary aggregation cited roughly $263 million of insider sales in June 2026, including about $250 million linked to CEO Henry Samueli, though this figure is not directly traceable to a single primary filing.
Analysts Maintain Buy Ratings Amid Pullback
Jefferies reiterated a Buy rating with a $550 12‑month price target, citing improved visibility for calendar 2028, an on‑track Tensor Processing Unit (TPU) roadmap, and a broadening application-specific integrated circuit (ASIC) customer base. Its scenario analysis projects calendar 2028 earnings per share (EPS) of $30–$40, implying about a 10-times price-to-earnings multiple at that target [source:5].
Citi maintained a Buy rating with a $500 target, calling Broadcom’s post-earnings pullback a buy‑the‑dip opportunity after management did not raise near-term AI revenue expectations for fiscal 2026 and 2027. Bank of America raised its price target to $530, projecting AI revenue growth of roughly 180% in fiscal 2026 and nearly 100% in fiscal 2027 [source:12].
JPMorgan raised its target to $580, saying second-quarter results reinforced a positive long-term growth outlook and that Broadcom’s TPU v9 2nm chip remains on track for 2028. Other firms set targets including Benchmark at $545, CLSA at $600, Susquehanna at $490, and Truist at $550.
Across 33 analysts, the consensus registers as a Moderate Buy, with an average 12-month target of $493.24 and a high/low range of $582/$375. The rating breakdown shows zero sell ratings, three holds, and 30 buys, including one strong buy.
Broadcom shares traded higher in premarket alongside semiconductor and artificial-intelligence stocks as sector sentiment strengthened.
The contrast between affiliate and equity-compensation filings increasing potential near-term share supply and broad buy‑the‑dip calls anchored in a multi-year AI roadmap through 2028 frames the trading debate for Broadcom. Investors will weigh immediate liquidity signals against analyst bets that custom AI accelerators and ASIC wins underpin earnings into the next cycle.
